← All chips

AI accelerator · China

Iluvatar CoreX TianGai 100 / BI series

China's first 7nm cloud training GPGPU to reach volume production (2021-2022), with 147 FP16 TFLOPS and 32GB HBM2; the BI line extends to the TianGai 150 (64GB HBM2e) and Zhikai 100 inference cards. Sold mainly B2B, though a JD self-operated listing near 80,000 CNY has been observed.

ChinaShippingIluvatar CoreX (天数智芯)BI (天垓) familyLaunched 2021-037nm, 2.5D CoWoS, ~24B transistors

Latest observation ~$11.3K (from ¥79,999 at 2023 avg 7.08 CNY/USD) (per card) as of 2023 · researched 2026-08-27

~$11.3Klatest observation · reseller listing · 2023 · from ¥79,999
1dated price observations on record
6sourced specs (all linked below)

Specifications

Sourced specs

SpecValueSource
FP16 compute147 TFLOPSvia iluvatar.com2026-08
INT8 compute~295 TOPSvia iluvatar.com2026-08
Memory32GB HBM2, ~1.2 TB/svia iluvatar.com2026-08
TDP / form factor250 W board power, full-height full-length dual-slot, passivevia iluvatar.com2026-08
Host interfacePCIe Gen4 x16via iluvatar.com2026-08
Successor (TianGai 150 / BI-V150)64GB HBM2e, 350 W peakvia mirrorfrog.com2026-08

Pricing

Price history, newest first

DatePriceTypeSourceConfidence
2023~$11.3K from ¥79,999 at 2023 avg 7.08 CNY/USD per cardJD self-operated promo ~79,999元 (立减 to ~79,599元); capture date approximateReseller listingvia JD self-operated listing via SMZDMlow

vendor-official or multiple independent reports · single major report or several secondary · estimate or lone secondary source

Prices in USD, converted at each observation year's average exchange rate; the original figure and rate print under every converted price. How prices are sourced and graded ↗

Context

Notes

  • B2B-dominated vendor; no official list price.
  • Cumulative TianGai 100 orders approached RMB 200M by March 2022 (Zhidx), but no per-card price was disclosed; the JD listing below is the only public unit price found.

Where it sits

In the stack

All specs and prices link to their original sources, dated as observed. Figures are market observations, not offers; treat each as of its date.